Researcher.Life Logo

Atherosclerosis Plus : Impact Factor & More

eISSN: 2667-0895pISSN: 2667-0909
JournalOpen Access

Key Metrics

CiteScore
2
Impact Factor
< 5
SNIP
0.42
Recommended pre-submission checks
Powered by Paperpal by Editage

Atherosclerosis Plus Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2050
Publication Time11
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEuropean Atherosclerosis Society
FrequencyContinuous publication
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Atherosclerosis Plus ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Atherosclerosis Plus

Calciprotein particles disrupt autophagy in vascular endothelial cells and smooth muscle cells.
  • 1 Sep 2026
  • Atherosclerosis plus
Associations of lipoprotein(a) concentrations with cardiovascular disease in men and women with primary hypercholesterolemia.
  • 1 Sep 2026
  • Atherosclerosis plus
Proprotein convertase subtilisin/kexin type 9-CC-motif chemokine ligand 2 interactions link lipoprotein(a) composition to intermediate monocyte inflammation in coronary artery disease.
  • 1 Sep 2026
  • Atherosclerosis plus
Plasma-derived small extracellular vesicle miR-660-5p as a predictor for carotid plaque vulnerability and postoperative major adverse cardiovascular event risk.
  • 1 Sep 2026
  • Atherosclerosis plus
Association between HIV infection and arterial stiffness: A population-based cross-sectional study from Rakai, South Western Uganda.
  • 1 Sep 2026
  • Atherosclerosis plus
Associations of NMR metabolic biomarkers and arterial calcification: An observational and Mendelian randomization study within the BBMRI metabolomics consortium.
  • 1 Jun 2026
  • Atherosclerosis plus
Calciprotein particles disrupt autophagy in vascular endothelial cells and smooth muscle cells.
  • 1 Sep 2026
  • Atherosclerosis plus
Associations of lipoprotein(a) concentrations with cardiovascular disease in men and women with primary hypercholesterolemia.
  • 1 Sep 2026
  • Atherosclerosis plus
Proprotein convertase subtilisin/kexin type 9-CC-motif chemokine ligand 2 interactions link lipoprotein(a) composition to intermediate monocyte inflammation in coronary artery disease.
  • 1 Sep 2026
  • Atherosclerosis plus
Plasma-derived small extracellular vesicle miR-660-5p as a predictor for carotid plaque vulnerability and postoperative major adverse cardiovascular event risk.
  • 1 Sep 2026
  • Atherosclerosis plus
Association between HIV infection and arterial stiffness: A population-based cross-sectional study from Rakai, South Western Uganda.
  • 1 Sep 2026
  • Atherosclerosis plus
Associations of NMR metabolic biomarkers and arterial calcification: An observational and Mendelian randomization study within the BBMRI metabolomics consortium.
  • 1 Jun 2026
  • Atherosclerosis plus

FAQs on Atherosclerosis Plus